Department of Health and Human Services January 31, 2019 – Federal Register Recent Federal Regulation Documents
Results 51 - 83 of 83
Ebola Virus Disease Therapeutics-Amendment
The Secretary is amending the February 27, 2015, Declaration issued pursuant to the Public Health Service Act, amended December 9, 2015 and December 2, 2016, to update the term ``Ebola Virus Disease'' to ``Ebola disease'' (EBOD) throughout the declaration and to clarify the definition of EBOD. The amendment also expands the Covered Countermeasures beyond the single therapeutic listed in prior declarations but limit coverage to Covered Countermeasures that are directly supported by the United States (U.S.) Federal Government, consistent with the terms of the Declaration, and is republishing the Declaration in its entirety as amended.
Ebola Virus Disease Vaccines-Amendment
The Secretary is amending the Declaration issued pursuant to the Public Health Service Act on December 3, 2014, as amended on December 1, 2015 and December 2, 2016, to update the term ``Ebola Virus Disease'' to ``Ebola disease'' (EBOD) throughout the declaration and to clarify the definition of EBOD. The amendment also expands the Covered Countermeasures beyond the three vaccines listed in prior declarations but limit coverage to Covered Countermeasures that are directly supported by the United States (U.S.) Federal Government, consistent with the terms of the Declaration, and is republishing the Declaration in its entirety as amended.
Partnership Opportunity To Identify Products for Fentanyl Exposure in Personal Protective Equipment Information Database; Reopening of the Comment Period
On October 18, 2018 the National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), published a notice in the Federal Register [83 FR 52834] announcing the availability of a Partnership Opportunity to Identify Products for Fentanyl Exposure in Personal Protective Equipment Information Database. Written comments were to be received by November 19, 2018. In response to requests from interested parties, NIOSH is announcing the reopening of the comment period.
Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2019; Medicare Shared Savings Program Requirements; Quality Payment Program; Medicaid Promoting Interoperability Program; Quality Payment Program-Extreme and Uncontrollable Circumstance Policy for the 2019 MIPS Payment Year; Provisions From the Medicare Shared Savings Program-Accountable Care Organizations Pathways to Success; and Expanding the Use of Telehealth Services for the Treatment of Opioid Use Disorder Under the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act; Correction
This document corrects technical errors that appeared in the final rule published in the Federal Register on November 23, 2018 entitled ``Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2019; Medicare Shared Savings Program Requirements; Quality Payment Program; Medicaid Promoting Interoperability Program; Quality Payment Program Extreme and Uncontrollable Circumstance Policy for the 2019 MIPS Payment Year; provisions from the Medicare Shared Savings Program Accountable Care Organizations Pathways to Success; and Expanding the Use of Telehealth Services for the Treatment of Opioid Use Disorder under the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act.''
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.